Net profit of Bayer CropScience rose 179.82% to Rs 95.70 crore in the quarter ended December 2025 as against Rs 34.20 crore during the previous quarter ended December 2024. Sales rose 4.62% to Rs 1106.20 crore in the quarter ended December 2025 as against Rs 1057.40 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales1106.201057.40 5 OPM %10.591.91 - PBDT127.8048.70 162 PBT113.0033.60 236 NP95.7034.20 180 Powered by Capital Market - Live News

Bayer CropScience will hold a meeting of the Board of Directors of the Company on 11 February 2026.Powered by Capital Market - Live News

Net profit of Bayer CropScience rose 12.03% to Rs 152.70 crore in the quarter ended September 2025 as against Rs 136.30 crore during the previous quarter ended September 2024. Sales declined 10.60% to Rs 1553.40 crore in the quarter ended September 2025 as against Rs 1737.60 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales1553.401737.60 -11 OPM %13.2210.58 - PBDT214.70204.10 5 PBT200.30190.10 5 NP152.70136.30 12 Powered by Capital Market - Live News

Bayer CropScience announced that the Board of Directors of the Company at its meeting held on 07 November 2025, has recommended a Interim Dividend of Rs.90 per share (i.e.900%), subject to the approval of the shareholders.Powered by Capital Market - Live News

Bayer CropScience will hold a meeting of the Board of Directors of the Company on 7 November 2025.Powered by Capital Market - Live News